-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Tuesday's After-Market Session
Share
Listen to the news

Gainers

  • Exicure (NASDAQ:XCUR) stock rose 38.4% to $2.38 during Tuesday's after-market session. The market value of their outstanding shares is at $10.5 million.
  • Catheter Precision (AMEX:VTAK) stock moved upwards by 21.23% to $0.68. The market value of their outstanding shares is at $2.3 million.
  • Picard Medical (AMEX:PMI) shares increased by 16.42% to $0.16. The company's market cap stands at $14.6 million.
  • iSpecimen (NASDAQ:ISPC) shares increased by 15.89% to $2.77. The market value of their outstanding shares is at $3.3 million.
  • ALPS Group (NASDAQ:ALPS) shares rose 15.37% to $0.55. The company's market cap stands at $83.3 million.
  • BioCardia (NASDAQ:BCDA) stock rose 9.05% to $0.87. The company's market cap stands at $13.5 million.

Losers

  • Basel Medical Group (NASDAQ:BMGL) shares declined by 19.1% to $6.57 during Tuesday's after-market session. The market value of their outstanding shares is at $9.6 million.
  • NextCure (NASDAQ:NXTC) shares fell 10.34% to $5.9. The company's market cap stands at $7.8 million.
  • SANUWAVE Health (NASDAQ:SNWV) shares decreased by 10.22% to $10.74. The market value of their outstanding shares is at $96.8 million.
  • China Pharma Holding (AMEX:CPHI) stock decreased by 8.11% to $0.56. The company's market cap stands at $25.3 million.
  • Jasper Therapeutics (NASDAQ:JSPR) shares decreased by 7.3% to $0.67. The company's market cap stands at $17.0 million.
  • Liminatus Pharma (NASDAQ:LIMN) shares fell 6.67% to $0.1. The market value of their outstanding shares is at $6.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending